Catherine Owen Adams, Acadia Pharmaceuticals CEO
Acadia lands $150M sale of rare pediatric PRV
Acadia Pharmaceuticals has sold its priority review voucher for $150 million, the company said Tuesday, but did not disclose the buyer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
